Susceptibility to false discovery in biomarker research using liquid chromatography-high resolution mass spectrometry based untargeted metabolomics profiling

Clin Transl Med. 2021 Jun;11(6):e469. doi: 10.1002/ctm2.469.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism*
  • Biomedical Research
  • Case-Control Studies
  • Chromatography, Liquid / methods*
  • Data Interpretation, Statistical*
  • Disease*
  • False Positive Reactions
  • Humans
  • Mass Spectrometry / methods*
  • Metabolome*

Substances

  • Biomarkers